CDK2 Heterobifunctional Degraders Co-Degrade CDK2 and Cyclin E Resulting in Efficacy in CCNE1-Amplified and Overexpressed Cancers

CDK2 Heterobifunctional Degraders Co-Degrade CDK2 and Cyclin E Resulting in Efficacy in CCNE1-Amplified and Overexpressed Cancers

EORTC-NCI-AACR Symposium 2024

Nicholas Kwiatkowski, Tong Liang, Zhe Sha, Philip N. Collier, Annan Yang, Murugappan Sathappa, Atanu Paul, Lijing Su, Xiaozhang Zheng, Robert Aversa, Kunhua Li, Revonda Mehovic, Susanne B. Breitkopf, Dapeng Chen, Charles L. Howarth, Karen Yuan, Hakryul Jo, Joseph D. Growney, Matt Weiss, Juliet Williams